Literature DB >> 21847655

JWA enhances As₂O₃-induced tubulin polymerization and apoptosis via p38 in HeLa and MCF-7 cells.

Lianlian Shen1, Wenxia Xu, Aiping Li, Jian Ye, Jianwei Zhou.   

Abstract

Arsenic trioxide (As₂O₃) has potential anti-cancer activity against a wide range of carcinomas via apoptosis induction or oncoprotein degradation. The mechanisms involved are not fully elucidated. Here, we demonstrated that As₂O₃ induced-apoptosis in HeLa and MCF-7 cancer cells was in part triggered by tubulin polymerization. High expression of JWA promoted tubulin polymerization and increased the sensitivity of the cancer cells to As₂O₃. The activation of the p38 MAPK (mitogen-activated protein kinases) signaling pathway was found to contribute to JWA-promoted tubulin polymerization. Our results suggest that JWA may serve as an effective enhancer of microtubule-targeted As₂O₃ anti-cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21847655     DOI: 10.1007/s10495-011-0637-6

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  15 in total

1.  The opposite prognostic significance of nuclear and cytoplasmic p21 expression in resectable gastric cancer patients.

Authors:  Yefei Huang; Weimin Wang; Yansu Chen; Yulin Huang; Jianbing Zhang; Song He; Yongfei Tan; Fulin Qiang; Aiping Li; Oluf Dimitri Røe; Shouyu Wang; Yan Zhou; Jianwei Zhou
Journal:  J Gastroenterol       Date:  2013-10-15       Impact factor: 7.527

2.  Lack of JWA Enhances Neurogenesis and Long-Term Potentiation in Hippocampal Dentate Gyrus Leading to Spatial Cognitive Potentiation.

Authors:  Sha Sha; Jin Xu; Zi-Hong Lu; Juan Hong; Wei-Jun Qu; Jian-Wei Zhou; Ling Chen
Journal:  Mol Neurobiol       Date:  2014-11-30       Impact factor: 5.590

3.  Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma.

Authors:  Bin Wei; Qin Han; Lijuan Xu; Xiaohui Zhang; Jing Zhu; Li Wan; Yan Jin; Zhaoye Qian; Jingjing Wu; Yong Gao; Jianwei Zhou; Xiaofei Chen
Journal:  BMC Cancer       Date:  2015-04-30       Impact factor: 4.430

4.  JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.

Authors:  W Xu; Q Chen; Q Wang; Y Sun; S Wang; A Li; S Xu; O D Røe; M Wang; R Zhang; L Yang; J Zhou
Journal:  Cell Death Dis       Date:  2014-12-04       Impact factor: 8.469

5.  JWA regulates human esophageal squamous cell carcinoma and human esophageal cells through different mitogen-activated protein kinase signaling pathways.

Authors:  Jie Lin; Tieliang Ma; Xiaodong Jiang; Zhijun Ge; Weiliang Ding; Yuanyuan Wu; Guojun Jiang; Jiake Feng; Guoxing Cui; Yongfei Tan
Journal:  Exp Ther Med       Date:  2014-03-28       Impact factor: 2.447

6.  EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells.

Authors:  Yuan Li; Xin Shen; Xueming Wang; Aiping Li; Pengqi Wang; Pan Jiang; Jianwei Zhou; Qing Feng
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

7.  Cytosolic Ca2+ shifts as early markers of cytotoxicity.

Authors:  Philippe Wyrsch; Christian Blenn; Theresa Pesch; Sascha Beneke; Felix R Althaus
Journal:  Cell Commun Signal       Date:  2013-02-06       Impact factor: 5.712

8.  TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer.

Authors:  W Xu; S Wang; Q Chen; Y Zhang; P Ni; X Wu; J Zhang; F Qiang; A Li; O D Røe; S Xu; M Wang; R Zhang; J Zhou
Journal:  Cell Death Dis       Date:  2014-02-13       Impact factor: 8.469

9.  Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/β-catenin signaling pathway.

Authors:  Pengyu Zhang; Xuan Zhao; Wenjuan Zhang; Aili He; Bo Lei; Wanggang Zhang; Yinxia Chen
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

10.  JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells.

Authors:  Q Wang; Q Chen; L Zhu; M Chen; W Xu; S Panday; Z Wang; A Li; O D Røe; R Chen; S Wang; R Zhang; J Zhou
Journal:  Oncogenesis       Date:  2017-07-03       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.